ValuEngine cut shares of Merus N.V. (NASDAQ:MRUS) from a hold rating to a sell rating in a research note released on Monday, October 2nd.

Other equities analysts have also recently issued research reports about the company. Zacks Investment Research raised Merus N.V. from a sell rating to a hold rating in a research note on Wednesday, September 13th. Royal Bank Of Canada assumed coverage on Merus N.V. in a report on Thursday, September 14th. They set an outperform rating and a $28.00 price target for the company. Jefferies Group LLC reiterated a buy rating and set a $31.00 price target on shares of Merus N.V. in a report on Friday, July 14th. Finally, Wedbush reiterated an outperform rating and set a $32.00 price target on shares of Merus N.V. in a report on Tuesday, June 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of $30.50.

Merus N.V. (NASDAQ MRUS) traded up 0.05% on Monday, hitting $21.01. 18,392 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $18.59 and its 200-day moving average price is $18.59. The company’s market cap is $407.51 million. Merus N.V. has a 12-month low of $13.13 and a 12-month high of $29.75.

TRADEMARK VIOLATION WARNING: “Merus N.V. (MRUS) Stock Rating Lowered by ValuEngine” was first published by Marea Informative and is the property of of Marea Informative. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at http://www.mareainformativa.com/merus-n-v-mrus-cut-to-sell-at-valuengine/117360/.

A number of institutional investors and hedge funds have recently bought and sold shares of MRUS. Spark Investment Management LLC acquired a new stake in Merus N.V. in the 1st quarter worth approximately $458,000. Renaissance Technologies LLC acquired a new stake in Merus N.V. in the 1st quarter worth approximately $549,000. Victory Capital Management Inc. acquired a new stake in Merus N.V. in the 1st quarter worth approximately $976,000. Iguana Healthcare Management LLC lifted its holdings in Merus N.V. by 16.7% in the 1st quarter. Iguana Healthcare Management LLC now owns 175,000 shares of the biotechnology company’s stock worth $4,268,000 after purchasing an additional 25,000 shares during the last quarter. Finally, Wellington Management Group LLP acquired a new stake in Merus N.V. in the 1st quarter worth approximately $29,841,000. Hedge funds and other institutional investors own 32.16% of the company’s stock.

About Merus N.V.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for Merus N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus N.V. and related stocks with our FREE daily email newsletter.